common bpc 157 dose bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 Dosage Guide: How Much
Description
Join here.

Drab A, Kanadys W, Malm M, Wdowiak K, Dolar-Szczasny J, Barczyski B

doi: 10.1006/geno.1995.9966 21 RamsdenDBWaringRHParsonsRBBarlowDJWilliamsAC

Despite the current lack of conclusive human trials, its potential to aid in various forms of recovery is promising
